IASR Vol.43 No.12 (No. 514) November 2022 Coronavirus disease 2019 (COVID-19) as at November 2022, Japan

PDF download（PDF：541KB）

Coronavirus disease 2019 (COVID-19) as at November 2022, Japan

Epidemiological assessment of sex and age-related characteristics of COVID-19, by epidemic wave, Japan
Development of a pathogen genome surveillance system to facilitate public health measures
Monitoring and assessment of SARS-CoV-2 variants at the National Institute of Infectious Diseases
Pathogenicity assessment of SARS-CoV-2 variants based on animal models
Susceptibility evaluation of neutralizing antibodies and antiviral drugs against SARS-CoV-2 variants
Multilayered monitoring efforts for trends in the occurrence of COVID-19 in Japan
Utilization of multilayered monitoring and review of monitoring indicators for COVID-19 following the termination of notifiable disease surveillance for COVID-19 in Tokyo Metropolis
COVID-19 weekly report dissemination activities in Osaka Prefecture
Monitoring of human mobility at major train stations and urban areas, along with the public's anxiety and risk behaviors, to aid in assessing and evaluating COVID-19 activity levels
Active epidemiological investigation at the time of SARS-CoV-2 variant emergence
The first few hundred studies conducted as active epidemiological investigation of COVID-19 due to SARS-CoV-2 B.1.1.529 lineage (Omicron) infection
Increase in the number of patients with wheezing and a case of acute flaccid paralysis with enterovirus D68 detection, Tokyo Metropolis, Japan
The state of rubella surveillance in Japan
Outbreak due to ESBL-producing enterohemorrhagic Escherichia coli O157:H7
Outbreak of Salmonella Enteritidis infection presumed to be caused by food provided at a hospital
Pathogens detected in confirmed and suspected COVID-19 cases reported in the NESID Infectious Agents Surveillance System (January 2020 to December 2022)